Articles On Telix Pharmaceuticals (ASX:TLX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Here are the top 10 ASX 200 shares today
It was another bumpy session for ASX shares and the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After narrowly missing out on a rise yesterday, investors were in for a similar experience today, with... |
Motley Fool | TLX | 2 months ago |
|
Telix Announces Record-Breaking Presence at EANM 2025
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 30, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 2 months ago |
|
Closing Bell: Healthcare, banking and gold stocks give ASX an 0.86pc boost
ASX up 75 points to 8862.8 with 9 sectors higher Healthcare, banks and gold stocks drive gains Energy, info tech languish in the red ASX pushes higher alongside spot gold The ASX 200 hummed higher throughout the day, closing out up 0.86... |
Stockhead | TLX | 2 months ago |
|
Weekly Ratings, Targets, Forecast Changes – 26-09-25
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | TLX | 2 months ago |
|
ASX Market Open: Up today, but changed RBA tune may soon define Week 40 | Sep 29
Australian shares are heading into Week 40 in the green, according to ASX 200 futures, though whether that +0.4% gain holds through the trading week is up in the air, considering we have a Reserve Bank cut call looming. Listen to the Hot... |
themarketonline.com.au | TLX | 2 months ago |
|
Closing Bell: ASX tips up on resource strength as health sector flounders
ASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs on pharmaceuticals Strength in resources and banks outweighs greater market losses Markets take stock as tariffs fire back up After a pol... |
Stockhead | TLX | 2 months ago |
|
ASX 200 Spotlight: Pharma Tariffs, Silver Surge and Energy Moves
Highlights US pharma tariffs weigh on leading Australian healthcare stocks Silver outpaces gold in the commodities race Energy sector advances on European project updates Global tariffs weighed on healthcare names like... |
Kalkine Media | TLX | 2 months ago |
|
Brokers name 3 ASX shares to buy today
It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these... |
Motley Fool | TLX | 2 months ago |
|
CSL shares fall on new Trump tariff hit
It has been a tough finish to the week for the healthcare sector. In afternoon trade, the S&P/ASX 200 Health Care index is down 1.4%. This compares unfavourably to a small gain by the broader ASX 200 index. Here's the current state of p... |
Motley Fool | TLX | 2 months ago |
|
Why Telix Pharmaceuticals shares could rocket 50% in a year
It has been a difficult year for owners of Telix Pharmaceuticals Ltd (ASX: TLX) shares. A series of disappointing announcements has put significant pressure on the radiopharmaceuticals company's shares. However, Bell Potter notes that there... |
Motley Fool | TLX | 2 months ago |
|
5 things to watch on the ASX 200 on Friday
On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a mildly positive session and finished the day a fraction higher. The benchmark index rose 0.1% to 8,773 points. Will the market be able to bounce back from this on Friday and end the... |
Motley Fool | TLX | 2 months ago |
|
ASX 200 Stocks Face Fresh Lows Amid Tough Earnings Season
Highlights Several ASX-listed companies hit fresh yearly lows after earnings results. Weak outlooks and missed targets dominated across diverse sectors. Healthcare and consumer names emerged as focal points of investor conce... |
Kalkine Media | TLX | 2 months ago |
|
ASX 200 Lows: What’s Driving These Big Names Down?
Highlights Multiple well-known companies hit fresh one-year lows. Healthcare, consumer, and industrials sectors faced broad challenges. Missed earnings remain a recurring theme across these declines. Multiple ASX-liste... |
Kalkine Media | TLX | 2 months ago |
|
Top brokers name 3 ASX shares to buy today
Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brokers have named as buys this week are lis... |
Motley Fool | TLX | 2 months ago |
|
The Overnight Report: Awaiting August CPI
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets took a breather with profit taking most apparent in technology stocks as... |
FNArena | TLX | 2 months ago |
|
Buy alert! Expert says Telix shares could soar by 108% or even higher
2025 has been a tough year for Telix Pharmaceuticals Ltd (ASX: TLX) investors. Since the start of January, shares in the cancer diagnostics specialist have dropped by 31% to $16.38 per share at Tuesday's close. In comparison, the benc... |
Motley Fool | TLX | 2 months ago |
|
Here are the top 10 ASX 200 shares today
It was another strong session for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Tuesday. The ASX backed up yesterday's strong start to the trading week with another rise today. By the tim... |
Motley Fool | TLX | 2 months ago |
|
ASX 200 Spotlight: Market Movers and Sector Surges
Highlights: Key updates from aerospace, defence, rare earths, and biotech sectors Strong momentum in manufacturing and services across Australia Multiple ASX-listed companies deliver significant market activity ASX ses... |
Kalkine Media | TLX | 2 months ago |
|
‘We want to have a billion-dollar valuation’: Cyber warfare, biotech scaleups vie for major award
What does it take to be the best service provider in your field? Four leaders in defence tech, healthtech, executive recruitment and water infrastructure give us a glimpse. Ahead of the 2026 EY Entrepreneur Of The Year™ program’s 25th annua... |
Startup Daily | TLX | 2 months ago |
|
Why Clinuvel, DroneShield, Nuix, and Telix shares are storming higher today
The S&P/ASX 200 Index (ASX: XJO) is having a decent session on Tuesday. At the time of writing, the benchmark index is up 0.4% to 8,848.9 points. Four ASX shares that are rising more than most today are listed below. Here's why they ar... |
Motley Fool | TLX | 2 months ago |
|
Don't sell! Experts pick 3 ASX All Ords shares worth holding despite major price shifts
S&P/ASX All Ordinaries Index (ASX: XAO) shares are 0.37% higher at 9,137.7 points on Tuesday. The ASX All Ords has risen 8% over the year to date, but many stocks have experienced much larger moves in opposite directions. On Th... |
Motley Fool | TLX | 2 months ago |
|
Undervalued ASX Gems In Precision Medicine
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Flighty investors have caused share prices to fall in 2025, but MPC Markets' Mark Ga... |
FNArena | TLX | 2 months ago |
|
Why are Telix shares rocketing 22% today?
Telix Pharmaceuticals Ltd (ASX: TLX) shares are racing higher on Tuesday morning. At the time of writing, the radiopharmaceuticals company's shares are up 22% to $18.32. This compares favourably to a 0.3% gain by the ASX 200 index in early... |
Motley Fool | TLX | 2 months ago |
|
Buy these ASX shares before the rest of the market does
Sometimes the best opportunities come when the market is looking the other way. Right now, a handful of promising ASX shares are trading well below their recent highs or flying under the radar altogether. For investors willing to act early,... |
Motley Fool | TLX | 2 months ago |
|
IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 23, 2025 /PRNewswire/ – IMRA Surgical, an Australian-... |
FNArena | TLX | 2 months ago |
|
ASX 200 Weekly Highs and Lows: What Investors Need to Know
Highlights Key ASX-listed companies marked fresh yearly highs and lows across diverse sectors. Gold miners, REITs, and financial firms dominated the high ranks. Healthcare and discretionary sectors showed weakness with multi... |
Kalkine Media | TLX | 2 months ago |
|
Weekly Ratings, Targets, Forecast Changes – 19-09-25
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | TLX | 2 months ago |
|
Here are the top 10 ASX 200 shares today
It was an upbeat end to the trading week this Friday, with the S&P/ASX 200 Index (ASX: XJO) bouncing back to close 0.32% higher. After a few days of negative sentiment, investors evidently decided to... |
Motley Fool | TLX | 2 months ago |
|
Closing Bell: ASX climbs on healthcare strength as PME and TLX jump
ASX pares back early gains to lift 0.32pc Healthcare, tech, utilities drive gains Resources sector drags as gold prices slip from highs ASX gets clean bill of health The ASX was looking a little healthier today, adding 0.32% or 28.3 poi... |
Stockhead | TLX | 2 months ago |
|
Break it Down: Telix share price climbs following Citi coverage
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully looks into the share price increase of big gun radiopharmaceuticals company Telix Pharmaceuticals (ASX:TLX), which surge... |
Stockhead | TLX | 2 months ago |
|
Scott Power: ASX health stocks remain under pressure but Telix charts FDA path forward
ASX heath sector fell 0.37% over past five days, while broader markets down 0.5% Telix finds way forward with the FDA on brain cancer imaging agent Pixclara Big Pharma to showcase Clever Culture Systems tech at major global conferences ... |
Stockhead | TLX | 2 months ago |
|
Navigate the ASX 200: Key Insights into Short Selling, Sector Trends, and Market Movements
Highlights Healthcare Sector Faces Challenges: Companies like (ASX:CSL) are experiencing significant declines. Gold Stocks Show Resilience: (ASX:RSG), (ASX:EVN), and (ASX:RRL) demonstrate notable gains. Short Selling Activities o... |
Kalkine Media | TLX | 2 months ago |
|
Pitt Street Research sees upside in ‘undervalued’ Imagion, tips ASX minnow as takeover target
Pitt Street Research says Imagion is significantly undervalued and sits around 75-80% below target range of 12.3 to 14.9 cents per share Research house sees further upside if MagSense imaging agent tech progresses to commercialisation in a... |
Stockhead | TLX | 2 months ago |
|
2 ASX stocks to buy today with $10,000
If you have $10,000 to invest in the ASX today, but don't know which stocks to choose, take a look at my two top picks for the week. NextDC Ltd (ASX: NXT) Outperformance of shares in the technology sector this week has helped to offs... |
Motley Fool | TLX | 2 months ago |
|
Here are the top 10 ASX 200 shares today
It was a day of relief for investors this Wednesday, as the S&P/ASX 200 Index (ASX: XJO) shook off the malaise that afflicted the markets earlier this week to push higher. By the time trading wrapp... |
Motley Fool | TLX | 2 months ago |
|
Why Megaport, Suncorp, Telix, and Westpac shares are pushing higher today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.25% to 8,827.1 points. Four ASX shares that are rising more than most today are listed below.... |
Motley Fool | TLX | 2 months ago |
|
After falling 29% in August, is this ASX 200 star the best share to buy today?
History tells us that September can be a turbulent month for ASX 200 shares as the dust settles on earnings season results. On trend, the S&P/ASX 200 Index (ASX: XJO) has shed 1.4% already this month. However, this can also be an... |
Motley Fool | TLX | 2 months ago |
|
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ — Telix Pharma... |
FNArena | TLX | 2 months ago |
|
The Overnight Report: Oracle Lights AI Fire (Again)
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets moved higher, tickling near all time high levels despite a downward revis... |
FNArena | TLX | 2 months ago |
|
ASX 200 Biotech Momentum: Artrya Leads Fresh Capital Wave Across Health Sector
Highlights Artrya (ASX:AYA) expands with major funding for heart disease detection devices Telix Pharmaceuticals (ASX:TLX) advances brain cancer imaging with FDA alignment Argenica Therapeutics (ASX:AGN) gains traction with... |
Kalkine Media | TLX | 2 months ago |
|
Banks, Miners, Retail And Healthcare In Focus ASX Shorting Trends
Highlights Short interest themes reshape focus across banks, miners, retail, and healthcare Coverage trends diverge as catalysts hit balance sheets and project pipelines Market tone split between cyclical caution and themati... |
Kalkine Media | TLX | 2 months ago |
|
Telix share price lifts off on big US FDA news
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.60. In earlier trade shares were up mo... |
Motley Fool | TLX | 2 months ago |
|
ASX 200 Short-Selling Watch: Highs, Lows, and Covering Themes Across Australian Sectors
Highlights Short-selling trends mapped to miners, banks, retail, healthcare, tech, and real estate Brief, entity-rich snapshots for each company referenced with one clean ticker mention Neutral tone focused on activity, sect... |
Kalkine Media | TLX | 2 months ago |
|
ASX 200 Short Sellers Target Travel, Food, and Biotech Stocks Amid Rising Bets
Highlights Short sellers increase activity across multiple S&P/ASX 200 companies, spanning travel, food, healthcare, and resources. Companies such as Flight Centre (ASX:FLT), Domino’s Pizza (ASX:DMP), and Guzman y Gomez (ASX:... |
Kalkine Media | TLX | 3 months ago |
|
August In Review: Banks & Golds Drive Rally
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Despite at times a bruising August reporting season, the index topped new all time h... |
FNArena | TLX | 3 months ago |
|
Biocurious: ASX drug developers see a silver lining in the FDA’s interventionist approach
The FDA has requested more data from a slew of ASX drug developers requesting marketing approval, or permission to undertake a trial Telix has received two FDA ‘complete response’ letters, but the company says investors should not be conce... |
Stockhead | TLX | 3 months ago |
|
Can you guess the best and worst performing sectors during earnings season?
With earnings season over, investors may be reflecting on last month's results and significant share price moves. This exercise can provide insight into which companies and sectors have momentum behind them. It can also identify compani... |
Motley Fool | TLX | 3 months ago |
|
ASX stocks in America Top performers and laggards in focus
Highlights Companies like Telix (ASX:TLX), Austal (ASX:ASB), Pro Medicus (ASX:PME), and Cochlear (ASX:COH) continue to strengthen their US footprint. CSL (ASX:CSL), Reece (ASX:REH), Unibail-Rodamco-Westfield (ASX:URW), and Guzman... |
Kalkine Media | TLX | 3 months ago |
|
ASX 200 Short Sellers Target Reporting Season Misses
Highlights IPH and Monash IVF Group experience sharp increases in short interest following earnings updates Reliance Worldwide and Inghams see rising shorts amid weaker performance and outlooks Clinuvel and Novonix lead the... |
Kalkine Media | TLX | 3 months ago |
|
Weekly Ratings, Targets, Forecast Changes – 29-08-25
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | TLX | 3 months ago |